Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
WOCKPHARMA | BSE
5.90
1.68%
Healthcare
Drug Manufacturers-Specialty & Generic
30/09/2023
04/12/2023
357.25
356.00
364.50
351.05
Wockhardt Limited a pharmaceutical and biotechnology company manufactures and markets active pharmaceutical ingredients formulations bio-similars and vaccines in India the United States the United Kingdom Ireland Mexico Russia and internationally. It develops various molecules primarily in the areas of infectious diseases such as WCK 5222 WCK 4282 WCK 4873 WCK 771 and WCK 2349 and WCK 6777 molecules. The company's biopharmaceutical products include Glaritus an insulin analog; Wosulin an r-DNA insulin; Wepox a recombinant erythropoietin that is used in the treatment of anemia caused by cancer and chronic renal failure; and Biovac-B a hepatitis B vaccine. It also provides contract manufacturing services for sterile injectables lyophilization and other dosage forms; and research services. The company was founded in 1967 and is headquartered in Mumbai India. Wockhardt Limited is a subsidiary of Themisto Trustee Company Private Limited.
View LessPositive Momentum
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Smallcap (300M - 2B USD)
No Dividends (Dividend Yield = 0%)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
42.2%1 month
75.6%3 months
57.3%6 months
51.9%0
0
1.50
0.73
0.31
70.61
2.47
0
880.00M
51.48B
617.30M
0
2.26
840.60
10.90
-15.08
0
0
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
43.50
Range1M
132.05
Range3M
151.25
Rel. volume
0.41
Price X volume
36.81M